MEK inhibitors function by specifically inhibiting the activity of MEK1 and MEK2 enzymes, which are upstream of the ERK1/2 kinases in the MAPK/ERK pathway. By blocking MEK, these inhibitors prevent the downstream signaling that leads to cell proliferation and survival, thereby reducing the growth of cancer cells.
